You are here: vision-research.eu » People » Researcher » Cordeiro, M Francesca

M Francesca Cordeiro

Short CV

Professor Francesca Cordeiro is a clinician scientist with a specialist interest in the field of glaucoma and neurodegeneration.

She currently heads the "Glaucoma and Retinal Neurodegeneration Research Group" at the Institute of Ophthalmology, University College London and is an Honorary Consultant Ophthalmologist at the Western Eye Hospital, St Mary's NHS Trust in London.

She qualified in medicine from St Bartholomew’s Hospital University of London in 1987 and completed training in general and surgical ophthalmology at Moorfield’s Eye & St Thomas’ Hospitals in London in 2003.

Her research is focussed on the molecular mechanisms involved in either the treatment or pathogenesis of glaucoma and retinal neurodegenerative diseases. She has investigated novel and translational approaches to these problems, and has received a number of awards for her work including the 2005 Lewis Rudin Glaucoma Prize from the New York Academy of Medicine, the 2000 International Glaucoma Review Award, and the 1998 Moorfields Research Gold Medal.

Scientifc Interest

  • Retinal Neurodegeneration
  • Glaucoma
  • Non-invasive imaging

Memberships

  • Chariman of European Glaucoma Society (EGS) Neuroprotection SIG 2007
  • Member of the Royal College of Physicians since 1990
  • Member of the Royal College of Ophthalmologists since 1992
  • Member of the Association for Research in Vision and Ophthalmology (ARVO) since 1995
  • Member of UK & Eire Glaucoma Society since 1996

Research Group

Glaucoma & Retinal Neurodegeneration Research Group

Contact

UCL Institute of Ophthalmology

Bath Street
EC1V 9EL London
United Kingdom

Phone: +44207608 6938/6821
Fax: +44207608 6938/6821

Email:
M.Cordeiro[at]ucl.ac.uk

Website:
www.ucl.ac.uk/glaucoma-retinal-neurodegen/

Key Publications

  1. Guo L, Salt TE, Luong V, Wood NE, Cheung W, Maass A, Ferrari G, Russo-Marie F, Sillito
    AM, Cheetham ME, Moss SE, Fitzke FW, Cordeiro MF:
    Targeting Amyloid-ß in glaucoma treatment.
    Proceedings of the National Academy of Science 2007; 104(33):13444-13449
    This paper described a brand new approach to glaucoma treatment and strengthened a link between Alzheimer’s and glaucoma, and was reported in Science and JAMA as being an important breakthrough.
  2. Cordeiro, MF, Guo L, Luong V, Harding G, Wang W, Jones HE, Moss SE, Sillito AM &
    Fitzke FW.
    Real time imaging of single nerve cell apoptosis in retinal neurodegeneration.
    Proceedings of the National Academy of Science 2004; 101: 13352-13356.
    This paper was awarded the Lewis Rudin Award in Glaucoma ($50,000) by the New York Academy of Medicine for the most scholarly international glaucoma publication for the year
  3. Guo L, Moss SE, Alexander RA, Ali RR, Fitzke F W & Cordeiro M F.
    Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure (IOP) and IOP-induced effects on extracellular matrix.
    Investigative Ophthalmology and Visual Science. 2005; 46(1):175-82.
    This paper was selected as being in the Top Ten international glaucoma publications for the year by the Associated International Glaucoma Societies.
  4. Guo L, Salt TE, Maass A, Luong V, Moss SE, Fitzke F W & Cordeiro M F.
    Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo.
    Investigative Ophthalmology and Visual Science. 2006; 47(2):626-33.
    This paper has been highlighted as a breakthrough for in vivo monitoring of effects of neuroprotection in glaucoma
  5. Cordeiro MF, Gay JA and Khaw PT.
    Human Anti-TGF-ß2 monoclonal antibody: a new antiscarring agent for glaucoma filtration surgery.
    Investigative Ophthalmology and Visual Science 1999; 40: 2225-34.
    This paper was awarded the International Glaucoma Review Prize ($25,000) by the Associated International Glaucoma Societies for the best international glaucoma publication for the year

Research Groups

People